Scarlett Johnson to Infliximab
This is a "connection" page, showing publications Scarlett Johnson has written about Infliximab.
Connection Strength
0.714
-
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
Score: 0.714
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.